Suppr超能文献

鉴定与儿童格雷夫斯病相关的新型环境物质。

Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease.

机构信息

Department of Endocrinology, Genetics and Metabolism, Children's Hospital of Soochow University, Suzhou, China.

Department of Biochemistry and Molecular Biology, School of Medical and Biological Sciences, Soochow University, Suzhou, China.

出版信息

Front Endocrinol (Lausanne). 2021 Jun 23;12:691326. doi: 10.3389/fendo.2021.691326. eCollection 2021.

Abstract

Graves' disease (GD) is the most common cause of hyperthyroidism, yet a relatively rare disease in the pediatric population. GD is a complex disorder influenced by both genetic and environmental factors. In this study, we aimed to find new environmental factors influencing the pathogenesis of GD. We investigated serum substances in 30 newly diagnosed GD children and 30 age- and gender-matched healthy controls. We measured total iodine by inductively coupled plasma-mass spectrometry (ICP-MS), analyzed perfluorinated compounds ultra-high-performance liquid chromatography coupled with multiple reaction monitoring mass spectrometry (UHPLC-MRM-MS), and explored other environmental substances using ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS) analysis. Twenty-nine single-nucleotide polymorphisms (SNPs) in eight genes related to GD were analyzed by SNaPshot. The serum total iodine was significantly higher in GD group, but its association with GD onset was weak, only with Exp(B) value near 1. The perfluorinated compound levels were not different between the two groups. More importantly, we found 16 environmental substances significantly different between GD and control groups, among which ponasterone A is a risk factor ( = 0.007 and Exp(B) = 14.14), while confertifoline is a protective factor against GD onset ( = 0.002 and Exp(B) = 0.001). We also identified 10 substances correlated significantly with thyroid indices in GD patients, among which seven associated with levels of the thyroid autoantibody TPOAb. No known SNPs were found predisposing GD. In this study, we explored a broad variety of environmental substances and identified novel factors that are potentially involved in the pediatric GD pathogenesis.

摘要

格雷夫斯病(GD)是最常见的甲状腺功能亢进症的病因,但在儿科人群中相对少见。GD 是一种受遗传和环境因素共同影响的复杂疾病。在这项研究中,我们旨在寻找影响 GD 发病机制的新环境因素。我们检测了 30 名新诊断的 GD 儿童和 30 名年龄和性别匹配的健康对照者的血清物质。我们通过电感耦合等离子体质谱法(ICP-MS)测量总碘,通过超高效液相色谱-串联质谱法(UHPLC-MRM-MS)分析全氟化合物,并用超高效液相色谱-四极杆飞行时间质谱法(UHPLC-QTOF/MS)分析其他环境物质。分析了与 GD 相关的八个基因中的 29 个单核苷酸多态性(SNP)。GD 组的血清总碘明显升高,但与 GD 发病的相关性较弱,仅接近 1 的 Exp(B)值。两组间的全氟化合物水平无差异。更重要的是,我们发现 GD 组和对照组之间有 16 种环境物质存在显著差异,其中波纳酮 A 是一个危险因素( = 0.007 和 Exp(B)= 14.14),而考非停是 GD 发病的保护因素( = 0.002 和 Exp(B)= 0.001)。我们还发现 10 种物质与 GD 患者的甲状腺指数显著相关,其中 7 种与甲状腺自身抗体 TPOAb 的水平相关。未发现已知的 SNP 与 GD 易感性相关。在这项研究中,我们探索了广泛的环境物质,并确定了可能参与儿科 GD 发病机制的新因素。

相似文献

1
Identification of Novel Environmental Substances Relevant to Pediatric Graves' Disease.
Front Endocrinol (Lausanne). 2021 Jun 23;12:691326. doi: 10.3389/fendo.2021.691326. eCollection 2021.
2
Comprehensive Metabolomics Study in Children With Graves' Disease.
Front Endocrinol (Lausanne). 2021 Nov 16;12:752496. doi: 10.3389/fendo.2021.752496. eCollection 2021.
4
Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene increases the risk of developing Graves' disease.
Int Immunopharmacol. 2014 Jun;20(2):366-9. doi: 10.1016/j.intimp.2014.03.019. Epub 2014 Apr 16.
5
Interleukin-21 is associated with disease activity in patients with Graves' disease.
Endocrine. 2014 Aug;46(3):539-48. doi: 10.1007/s12020-013-0105-x. Epub 2013 Nov 28.
6
Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Int Immunopharmacol. 2014 Jan;18(1):198-202. doi: 10.1016/j.intimp.2013.11.017. Epub 2013 Dec 2.
7
Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Clin Endocrinol (Oxf). 2010 Feb;72(2):248-55. doi: 10.1111/j.1365-2265.2009.03617.x. Epub 2009 Apr 27.
8
Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications.
Eur J Endocrinol. 2015 Jun;172(6):715-23. doi: 10.1530/EJE-14-0959. Epub 2015 Mar 12.
10
Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
Int Immunopharmacol. 2012 Oct;14(2):133-7. doi: 10.1016/j.intimp.2012.06.018. Epub 2012 Jul 5.

引用本文的文献

1
Puerarin inhibits inflammation and oxidative stress in female BALB/c mouse models of Graves' disease.
Transl Pediatr. 2024 Jan 29;13(1):38-51. doi: 10.21037/tp-23-370. Epub 2024 Jan 24.

本文引用的文献

1
Correlation of TSHR and CTLA-4 Single Nucleotide Polymorphisms with Graves Disease.
Int J Genomics. 2019 Sep 3;2019:6982623. doi: 10.1155/2019/6982623. eCollection 2019.
4
Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients.
Int J Biol Sci. 2018 Sep 7;14(11):1558-1570. doi: 10.7150/ijbs.24151. eCollection 2018.
5
Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.
J Ethnopharmacol. 2018 Jun 12;219:299-318. doi: 10.1016/j.jep.2018.03.026. Epub 2018 Mar 23.
6
Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis.
Oncotarget. 2017 Jun 28;8(60):102235-102243. doi: 10.18632/oncotarget.18704. eCollection 2017 Nov 24.
7
Is there any association between urinary metabolites of polycyclic aromatic hydrocarbons and thyroid hormone levels in children and adolescents?
Environ Sci Pollut Res Int. 2018 Jan;25(2):1962-1968. doi: 10.1007/s11356-017-0577-y. Epub 2017 Nov 5.
9
Oxidative status in children and adolescents with autoimmune thyroiditis.
Clin Exp Med. 2016 Nov;16(4):571-575. doi: 10.1007/s10238-015-0386-x. Epub 2015 Sep 5.
10
Type of fish consumed and thyroid autoimmunity in pregnancy and postpartum.
Endocrine. 2016 Apr;52(1):120-9. doi: 10.1007/s12020-015-0698-3. Epub 2015 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验